CC BY-NC-ND 4.0 · Sleep Sci 2024; 17(04): e461-e465
DOI: 10.1055/s-0044-1780503
Case Report

Excessive Postprandial Sleepiness in Two Young Adults Effectively Treated with Antidiabetic Medications

1   Department of Neurology, Iida Hospital, Iida City, Nagano Prefecture, Japan
,
Ryusuke Takaki
1   Department of Neurology, Iida Hospital, Iida City, Nagano Prefecture, Japan
,
Shigeto Sasaki
2   Department of Internal Medicine, Iida Hospital, Iida City, Nagano Prefecture, Japan
› Author Affiliations
Funding Source The authors declare that they have received no funding from agencies in the public, private or non-profit sectors for the conduction of the present study.

Abstract

We herein describe the cases of two young Japanese adults who presented with excessive daytime sleepiness (EDS). Based on their history, the postprandial nature of the sleepiness was suspected, although the patients themselves were not aware of the association. Oral glucose tolerance tests (OGTTs) reproduced the sleepiness and showed the patterns of insulin resistance (IR) compatible with type-2 diabetes mellitus (T2DM) in one patient and glucose intolerance in the other. There was no evidence of chronic hyperglycemia in either patient. Antidiabetic medications resulted in the disappearance of EDS in both patients; in one, a repeat OGTT revealed improved IR. We suggest that postprandial somnolence can present with EDS, and it can be effectively treated with antidiabetic medications, and that the OGTT can be useful in identifying IR, which may be the underliyng cause of the excessive postprandial somnolence.

Informed Consent

The signed consent form is retained by the corresponding author.


HEADINGS: Disorders of Excessive Somnolence. Postprandial Period. Glucose Tolerance Test. Insulin Resistance.




Publication History

Received: 28 May 2023

Accepted: 20 December 2023

Article published online:
10 May 2024

© 2024. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Guilleminault C, Brooks SN. Excessive daytime sleepiness: a challenge for the practising neurologist. Brain 2001; 124 (Pt 8): 1482-1491
  • 2 Gandhi KD, Mansukhani MP, Silber MH, Kolla BP. Excessive daytime sleepiness: A clinical review. Mayo Clin Proc 2021; 96 (05) 1288-1301
  • 3 Martins RC, Andersen ML, Tufik S. The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives. Braz J Med Biol Res 2008; 41 (03) 180-187
  • 4 Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005; 90 (08) 4510-4515
  • 5 Fernandez-Mendoza J, Vgontzas AN, Kritikou I, Calhoun SL, Liao D, Bixler EO. Natural history of excessive daytime sleepiness: role of obesity, weight loss, depression, and sleep propensity. Sleep 2015; 38 (03) 351-360
  • 6 Stahl ML, Orr WC, Bollinger C. Postprandial sleepiness: objective documentation via polysomnography. Sleep 1983; 6 (01) 29-35
  • 7 Xi Y, Lin Q, Yang Q. et al. Association between free sugars intake and excessive daytime sleepiness among Chinese adolescents. Nutrients 2021; 13 (11) 3959
  • 8 Lowden A, Holmbäck U, Akerstedt T, Forslund J, Lennernäs M, Forslund A. Performance and sleepiness during a 24 h wake in constant conditions are affected by diet. Biol Psychol 2004; 65 (03) 251-263
  • 9 Chervin RD, Aldrich MS. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 1999; 52 (01) 125-131
  • 10 Scharf MT. Reliability and efficacy of the Epworth Sleepiness Scale: Is there still a place for it?. Nat Sci Sleep 2022; 14: 2151-2156
  • 11 American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38: S8-S16
  • 12 Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008; 31 (08) 1650-1655
  • 13 Wang Q, Jokelainen J, Auvinen J. et al. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study. BMC Med 2019; 17 (01) 217
  • 14 American Academy of Sleep Medicine. The International Classification of Sleep Disorders Diagnosis and Coding Manual. Eds 3,. Winchester, IL: American Academy of Sleep Medicine;; 2014
  • 15 Nishimura R, Tanaka Y, Koiwai K. et al. Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. Cardiovasc Diabetol 2015; 14: 11
  • 16 Okada K, Yagyu H, Kotani K. et al. Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus. Endocr J 2013; 60 (07) 913-922
  • 17 Pyykkönen A-J, Isomaa B, Pesonen AK. et al. Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study. Diabetes Care 2012; 35 (11) 2271-2278
  • 18 Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9 (03) 211-224
  • 19 Barceló A, Barbé F, de la Peña M. et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63 (11) 946-950
  • 20 Otake K, Sasanabe R, Hasegawa R. et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009; 48 (21) 1863-1868